NCT06064786

Brief Summary

Aim: The aim of the current study was to compare and correlate gingival crevicular fluid (GCF) fetuin-A levels and high sensitivity C-reactive protein (hs-CRP) levels in non-diabetic periodontitis patients and type 2 diabetic periodontitis patients with healthy subjects and revealing its possible role in diagnosis of periodontal disease. Methodology: Forty-five periodontitis stage III patients categorized into 3 groups according to whether having type II diabetes mellitus or not were compared to systemically and periodontally healthy participants in this investigation. Clinical parameters for all groups were recorded. Assessment of GCF levels of fetuin A and hs-CRP were done to all enrolled participants utilizing an enzyme linked immune-sorbent assay (ELISA) kit. Receiver operating characteristic (ROC) curve was performed to reveal sensitivity, specificity, predictive value and diagnostic accuracy of the markers used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2023

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

September 20, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 3, 2023

Completed
Last Updated

October 3, 2023

Status Verified

September 1, 2023

Enrollment Period

2 months

First QC Date

September 20, 2023

Last Update Submit

September 26, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • GCF levels of fetuin A and hsCRP evaluation in all groups

    ELIZA kits

    levels of fetuin A and hsCRP are measured at baseline after the completion of all GCF sample collection carried at the day of enrollment of subjects in the investigation after diagnosis confirmation

Study Arms (3)

Group I

15 healthy patients with generalized periodontitis stage III.

Diagnostic Test: GCF levels of fetuin A and hsCRP evaluation

Group II

15 patients suffering from type 2 diabetes mellitus with generalized periodontitis stage III

Diagnostic Test: GCF levels of fetuin A and hsCRP evaluation

Group III

15 systemically healthy patients without periodontitis

Diagnostic Test: GCF levels of fetuin A and hsCRP evaluation

Interventions

ELIZA kits are used for GCF levels of fetuin A and hsCRP evaluation

Group IGroup IIGroup III

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

individuals recruited from outpatient clinic of periodontology department

You may qualify if:

  • both gender periodontitis stage III

You may not qualify if:

  • Smoking,
  • Systemic diseases (except DM in group B),
  • Periodontitis patients having periodontal treatment recently (past 6 months),
  • Pregnancy, lactation, contraceptive pills,
  • Anti-inflammatory/ immunosuppressive drugs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of dentistry, Fayoum university

Al Fayyum, Egypt

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

GCF samples

MeSH Terms

Conditions

Chronic Periodontitis

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

September 20, 2023

First Posted

October 3, 2023

Study Start

August 1, 2023

Primary Completion

September 15, 2023

Study Completion

September 15, 2023

Last Updated

October 3, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations